Enrichment of human ESC-derived multipotent mesenchymal stem cells with immunosuppressive and anti-inflammatory properties capable to protect against experimental inflammatory bowel disease.
about
Mesenchymal stem cells for the treatment of neurodegenerative and psychiatric disordersLent-On-Plus Lentiviral vectors for conditional expression in human stem cellsComprehensive transcriptomic and proteomic characterization of human mesenchymal stem cells reveals source specific cellular markersDetailed Characterization of Mesenchymal Stem/Stromal Cells from a Large Cohort of AML Patients Demonstrates a Definitive Link to Treatment Outcomes.Bone marrow mesenchymal stem cells from patients with aplastic anemia maintain functional and immune properties and do not contribute to the pathogenesis of the disease.Mesenchymal stem cell population derived from human pluripotent stem cells displays potent immunomodulatory and therapeutic propertiesFunctional comparison of human-induced pluripotent stem cell-derived mesenchymal cells and bone marrow-derived mesenchymal stromal cells from the same donor.Mesenchymal stem cells and their therapeutic applications in inflammatory bowel disease.Mesenchymal stem cells: Emerging mechanisms of immunomodulation and therapy.Small molecule mesengenic induction of human induced pluripotent stem cells to generate mesenchymal stem/stromal cellsCD39 modulates hematopoietic stem cell recruitment and promotes liver regeneration in mice and humans after partial hepatectomy.MSCs derived from iPSCs with a modified protocol are tumor-tropic but have much less potential to promote tumors than bone marrow MSCs.Comparison of immunological characteristics of mesenchymal stem cells derived from human embryonic stem cells and bone marrow.Human embryonic stem cell-derived mesenchymal stromal cells.Mesenchymal Stem/Stromal Cells Derived from Induced Pluripotent Stem Cells Support CD34(pos) Hematopoietic Stem Cell Propagation and Suppress Inflammatory Reaction.The secretome of stem cells isolated from the adipose tissue and Wharton jelly acts differently on central nervous system derived cell populations.Heterogeneous Differentiation of Human Mesenchymal Stem Cells in 3D Extracellular Matrix Composites.Mesenchymal stem cells as a treatment for peripheral arterial disease: current status and potential impact of type II diabetes on their therapeutic efficacy.Concise review: mesenchymal stem cells and translational medicine: emerging issues.Mesenchymal stem cells alleviate TNBS-induced colitis by modulating inflammatory and autoimmune responses.Human umbilical cord-derived mesenchymal stem cells protect against experimental colitis via CD5(+) B regulatory cellsModeling sarcomagenesis using multipotent mesenchymal stem cells.Tendon regeneration in human and equine athletes: Ubi Sumus-Quo Vadimus (where are we and where are we going to)?Modulating the biochemical and biophysical culture environment to enhance osteogenic differentiation and maturation of human pluripotent stem cell-derived mesenchymal progenitors.Advances in stem cells, induced pluripotent stem cells, and engineered cells: delivery vehicles for anti-glioma therapy.Current status of pluripotent stem cells: moving the first therapies to the clinic.A Comparison of Culture Characteristics between Human Amniotic Mesenchymal Stem Cells and Dental Stem Cells.NF-κB activation impairs somatic cell reprogramming in ageing.Human bone marrow stromal cells lose immunosuppressive and anti-inflammatory properties upon oncogenic transformation.Effect of Secreted Molecules of Human Embryonic Stem Cell-Derived Mesenchymal Stem Cells on Acute Hepatic Failure Model.Human embryonic stem cell-derived mesenchymal stromal cells ameliorate collagen-induced arthritis by inducing host-derived indoleamine 2,3 dioxygenaseExosomes from embryonic mesenchymal stem cells alleviate osteoarthritis through balancing synthesis and degradation of cartilage extracellular matrix.A therapy-grade protocol for differentiation of pluripotent stem cells into mesenchymal stem cells using platelet lysate as supplement.Human Adipose-Derived Mesenchymal Stem Cells Modulate Experimental Autoimmune Arthritis by Modifying Early Adaptive T Cell Responses.Treatment of Diabetes Mellitus Using iPS Cells and Spice PolyphenolsMulti-therapeutic effects of human adipose-derived mesenchymal stem cells on radiation-induced intestinal injuryMesenchymal Stromal Cells Mitigate Experimental Colitis via Insulin-like Growth Factor Binding Protein 7-mediated ImmunosuppressionHuman ESC-derived MSCs outperform bone marrow MSCs in the treatment of an EAE model of multiple sclerosis.Characterization of Mesenchymal Stem Cell-Like Cells Derived From Human iPSCs via Neural Crest Development and Their Application for Osteochondral Repair.Kindlin-2 Modulates the Survival, Differentiation, and Migration of Induced Pluripotent Cell-Derived Mesenchymal Stromal Cells
P2860
Q26801575-BCCB34B9-8ED7-4413-ABAE-54A424DEA699Q28595666-62E777E3-5B79-4C67-8D21-CD943E7B3BB5Q30390895-B32829E7-0E1D-4F69-9F06-F6787DD17C00Q33795203-AE9EAD8F-99B4-45EE-B9D8-BC64B66D17A8Q33828556-ED4DE102-CAE2-4077-8B1D-C8050FC15317Q33861809-B215D2E0-8F75-4A52-9C14-A1C8ABE17023Q33862395-CB338F1D-3CBD-4862-887D-9B52A0D48F56Q33914228-50B64A6F-E45E-4753-8E9C-1E7BF4D7C25DQ34259085-3F067553-1894-432D-B401-EE452465C67AQ34314607-64A8EBE2-1AF6-4EC4-8567-E4AC0C1247AAQ34569461-CE7822C5-949F-4BAC-B538-401B979907D6Q34985576-B60DB94A-5707-4F04-AF46-B4E179A3D2E6Q35100235-319FB770-79FE-476B-9063-ED488A247C40Q35681446-F08DF794-94B0-4F81-9215-BC049BF95588Q35818125-BCD71A46-2B49-455F-A1D8-A5152593644AQ36084814-646D7FB2-AB65-4C6A-85C1-A9EB302AEE45Q36554905-F2A50A78-CE84-470E-966F-019522A0FFA7Q36930468-151B5AE5-B3FD-4099-BA26-7BD9F848C821Q37056276-756E82E9-D03D-47DC-95DA-7DE59C92A97DQ37068242-55375234-3EF1-4E16-8FAB-251A51956A98Q37169313-44CB83DD-E577-4539-89AA-1472C1788132Q37935534-E6F0767B-9070-413A-84B6-1E9B26537F90Q38042089-2316AF45-AB48-4F4E-81AA-272E4EAF262FQ38134206-89DAD523-CDF1-4DAA-9AB0-353EC54162B2Q38227489-8F8B21A6-E2FE-43DE-BFA9-329B3DED80CBQ38590664-6BF3599D-FFD2-4A8E-A19F-4A52154E61ABQ38730229-F8936BD4-5059-419E-B1BB-BB290EB4AB9EQ38848975-5B8F9482-6679-4ACE-8327-3B3BDACA0758Q38943709-44A68028-6182-4341-ACC2-075246921A4AQ39347132-EA7979CD-BCA8-4ED7-A16E-757E5320DF35Q39804300-548E38E6-9F51-47C1-A2F6-D6096C0ADA46Q40094289-E5AA482B-3CC5-4284-AAE2-E8C114850320Q40178972-DE3C1F9A-0755-4DE5-996A-6B9DCBC36CB7Q40702107-020082F3-1482-4669-9647-0C0615DE9524Q41025468-9858FC64-86BA-44B5-B7C1-2990992A51BDQ41360309-D15E031F-2A89-4C1D-9668-6230FB847C14Q41653934-96DED89F-6AD0-457C-A866-3C7DB72997BEQ41900937-C7A292AB-8C27-48F6-A17C-C00BE50A75B1Q42087648-765E14CF-95CC-4188-AFA5-B7B80865F08EQ42158332-A6EFD7CA-FE78-4B14-B546-340CDA3D6F8C
P2860
Enrichment of human ESC-derived multipotent mesenchymal stem cells with immunosuppressive and anti-inflammatory properties capable to protect against experimental inflammatory bowel disease.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Enrichment of human ESC-derive ...... al inflammatory bowel disease.
@en
Enrichment of human ESC-derive ...... al inflammatory bowel disease.
@nl
type
label
Enrichment of human ESC-derive ...... al inflammatory bowel disease.
@en
Enrichment of human ESC-derive ...... al inflammatory bowel disease.
@nl
prefLabel
Enrichment of human ESC-derive ...... al inflammatory bowel disease.
@en
Enrichment of human ESC-derive ...... al inflammatory bowel disease.
@nl
P2093
P2860
P50
P356
P1433
P1476
Enrichment of human ESC-derive ...... tal inflammatory bowel disease
@en
P2093
Clara Bueno
Gertrudis Ligero
Iván Gutierrez-Aranda
Laura Sánchez
Ruth Rubio
Verónica Ramos
P2860
P304
P356
10.1002/STEM.569
P577
2011-02-01T00:00:00Z